Victor Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 20 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -7.53%
(FY 2021)
- Profit -33.69%
(FY 2021)
- Ebitda -4.07%
(FY 2021)
- Net Worth -82.54%
(FY 2021)
- Total Assets -0.35%
(FY 2021)
About Victor Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sivaparvathi Kavuri and Leelavathi Gonuguntla serve as directors at the Company.
- CIN/LLPIN
U01100TG2004PTC044805
- Company No.
044805
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Victor Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivaparvathi Kavuri  | Director | 19-Jan-2019 | Current |
| Leelavathi Gonuguntla | Director | 08-Dec-2004 | Current |
Financial Performance of Victor Biotech.
Victor Biotech Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.53% decrease. The company also saw a substantial fall in profitability, with a 33.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 82.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Victor Biotech?
In 2021, Victor Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivashakti Agritec LimitedActive 26 years 11 monthsSivaparvathi Kavuri and Leelavathi Gonuguntla are mutual person
Dia Builders LlpActive 1 year 9 monthsSivaparvathi Kavuri and Leelavathi Gonuguntla are mutual person
- Sathya Hybrid Seed Private LimitedActive 15 years 7 months
Sivaparvathi Kavuri and Leelavathi Gonuguntla are mutual person
- Golden Organic Product LimitedActive 11 years 28 days
Sivaparvathi Kavuri and Leelavathi Gonuguntla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Victor Biotech?
Unlock and access historical data on people associated with Victor Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Victor Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Victor Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
